| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |